Arcus Biosciences shares climbed Tuesday as enthusiasm grows for the biotech company's experimental cancer drug, a rival to Merck.

Merck has completed its previously announced acquisition of Verona Pharma plc. Verona Pharma is now a wholly-owned subsidiary ...

Merck & Co., Inc. just delivered a punch of good news with its latest WINREVAIR trial results, sending its stock up by a cool ...

Merck is attractively valued, boasting strong free cash flow, robust margins, and a leading position in oncology with ...

Merck & Co., Inc. recently announced a significant breakthrough in its Phase 3 HYPERION trial, targeting pulmonary arterial ...

Wall Street analysts expect the subcutaneous version of Keytruda, which just launched last week, to help soften the blow when the original loses patent protection later this decade.

Germany’s life sciences and pharma company Merck KGaA has appointed Kai Beckmann as future chairman of the executive board and chief executive of the firm.

Merck KGaA's chief executive Belén Garijo will end her time at the helm of the company next April, five years after taking ...

The two companies will leverage automation, data and AI to streamline drug discovery, development and manufacturing.

Shares of Merck & Co. Inc. slumped Tuesday, after the drug giant reported a rare revenue miss amid disappointing sales of two of its three biggest drugs and announced a $3 billion cost-cutting plan ...

São Tome and Principe / Mumbai (Maharashtra) [India], September 22: Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative ...

The FDA approved Merck's Keytruda Qlex, a new under-the-skin version of the cancer drug that can be injected in just 1-2 minutes, offering faster and more convenient treatment than traditional IV ...